SORRENTO DEVELOPS STI-4398 (COVIDTRAP™ PROTEIN) FOR POTENTIAL PREVENTION AND TREATMENT OF SARS-COV-2 CORONAVIRUS DISEASE (COVID-19)

Ads

You May Also Like

Aduro Biotech to Present at LEERINK Partners Roundtable Series

BERKELEY, Calif., Sept. 22, 2016 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ:ADRO) today announced ...

Cyclacel Pharmaceuticals to Present at the Ladenburg Thalmann 2018 Healthcare Conference

BERKELEY HEIGHTS, N.J., Sept. 26, 2018 (GLOBE NEWSWIRE) -- Cyclacel Pharmaceuticals, Inc. (Nasdaq:CYCC, Nasdaq:CYCCP) ...